Jordi Antón

17.1k total citations · 1 hit paper
172 papers, 4.5k citations indexed

About

Jordi Antón is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Jordi Antón has authored 172 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Hematology, 42 papers in Molecular Biology and 41 papers in Immunology. Recurrent topics in Jordi Antón's work include Autoimmune and Inflammatory Disorders Research (65 papers), Inflammasome and immune disorders (37 papers) and Kawasaki Disease and Coronary Complications (23 papers). Jordi Antón is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (65 papers), Inflammasome and immune disorders (37 papers) and Kawasaki Disease and Coronary Complications (23 papers). Jordi Antón collaborates with scholars based in Spain, Italy and United States. Jordi Antón's co-authors include Alessandro Plebani, Rosa Bou, Juan I. Aróstegui, Jordi Yagüe, Marco Gattorno, Estíbaliz Ruiz‐Ortiz, David Brough, María Barberà-Cremades, Fatima Martín‐Sánchez and Segundo Buján and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Jordi Antón

153 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response

2014 640 citations Jordi Yagüe, Jordi Antón et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jordi Antón Spain	35	1.6k	1.6k	1.1k	792	699	172	4.5k
Gabriele Simonini Italy	33	1.1k 0.7×	752 0.5×	1.2k 1.1×	777 1.0×	535 0.8×	229	4.0k
Yackov Berkun Israel	38	1.2k 0.8×	1.3k 0.8×	666 0.6×	550 0.7×	662 0.9×	120	4.0k
Francesco Ciccia Italy	43	1.8k 1.1×	2.9k 1.8×	1.7k 1.5×	750 0.9×	605 0.9×	232	7.1k
Ayşı̇n Bakkaloğlu Türkiye	40	3.7k 2.3×	1.3k 0.8×	635 0.6×	896 1.1×	1.2k 1.7×	176	6.5k
Salvatore Albani United States	38	1.5k 0.9×	2.3k 1.5×	1.2k 1.1×	395 0.5×	246 0.4×	121	5.2k
Thomas J A Lehman United States	35	648 0.4×	1.1k 0.7×	790 0.7×	1.3k 1.6×	756 1.1×	106	4.2k
Michèlle Rosenzwajg France	39	959 0.6×	3.2k 2.0×	384 0.3×	585 0.7×	830 1.2×	103	6.0k
Timothy R. D. J. Radstake Netherlands	39	1.3k 0.8×	2.5k 1.6×	404 0.4×	357 0.5×	369 0.5×	174	5.4k
Tomoyuki Imagawa Japan	29	860 0.5×	853 0.5×	1.5k 1.3×	896 1.1×	452 0.6×	150	3.3k
Troels Herlin Denmark	39	1.0k 0.6×	937 0.6×	2.2k 1.9×	776 1.0×	204 0.3×	241	5.4k

Countries citing papers authored by Jordi Antón

Since Specialization

Citations

This map shows the geographic impact of Jordi Antón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordi Antón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordi Antón more than expected).

Fields of papers citing papers by Jordi Antón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jordi Antón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordi Antón. The network helps show where Jordi Antón may publish in the future.

Co-authorship network of co-authors of Jordi Antón

This figure shows the co-authorship network connecting the top 25 collaborators of Jordi Antón. A scholar is included among the top collaborators of Jordi Antón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jordi Antón. Jordi Antón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Foeldvari, Ivan, Ameenat Lola Solebo, Harry Petrushkin, et al.. (2025). Monitoring of Juvenile Idiopathic Arthritis–Associated Uveitis in Long‐Term Disease Remission: Consensus‐Based Recommendations From the Multinational Interdisciplinary Working Group for Uveitis in Childhood. Arthritis Care & Research. 77(9). 1106–1111.

Clemente, Daniel, Alina Boteanu, Juan Carlos Nieto‐González, et al.. (2024). Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry. Pediatric Rheumatology. 22(1). 66–66. 1 indexed citations

Brunner, Hermine I., Anna Shmagel, Gerd Horneff, et al.. (2024). Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open‐Label, Phase 1 Trial. Arthritis Care & Research. 77(5). 584–593. 4 indexed citations

Hernández‐Rodríguez, José, Sergio Prieto‐González, Jordi Antón, et al.. (2024). Characterizing Protracted Febrile Myalgia: Fasciitis and Vasculitis of the Fascia and Muscle as Novel Histopathological Features. Journal of Clinical Medicine. 13(24). 7630–7630.

Foeldvari, Ivan, Harry Petrushkin, Regitze Bangsgaard, et al.. (2024). A practical approach to uveitis screening in children with juvenile idiopathic arthritis. British Journal of Ophthalmology. 109(3). 372–376. 3 indexed citations

Foeldvari, Ivan, Kathryn S. Torok, Jordi Antón, et al.. (2023). Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022. Expert Review of Clinical Immunology. 20(4). 387–404. 2 indexed citations

Benedetti, Fabrizio De, Alexei A. Grom, Paul Brogan, et al.. (2023). Efficacy and safety of emapalumab in macrophage activation syndrome. Annals of the Rheumatic Diseases. 82(6). 857–865. 67 indexed citations

Acevedo, Daniel, Núria Baños, Andrea Pluma, et al.. (2023). Expected impact of immunomodulatory agents during pregnancy: A newborn's perspective. Pediatric Allergy and Immunology. 34(2). e13911–e13911. 6 indexed citations

Antón, Jordi, et al.. (2022). Non-criteria manifestations in the presence of antiphospholipid antibodies in a paediatric cohort. Lara D. Veeken. 61(11). 4465–4471.

10.

Salvatore, Silvia, Massimo Agosti, Serena Arrigo, et al.. (2021). A Systematic Review of Gastrointestinal Manifestations in Children Presenting with COVID-19. INFM-OAR (INFN Catania). 9. 1–11. 1 indexed citations

11.

García‐Salido, Alberto, et al.. (2021). Spanish consensus document on diagnosis, stabilisation and treatment of pediatric multisystem inflammatory syndrome related to SARS-CoV-2 (SIM-PedS). SHILAP Revista de lepidopterología. 94(2). 116.e1–116.e11. 18 indexed citations

12.

Grasa, Carlos, Elisa Fernández-Cooke, Judith Sánchez-Manubens, et al.. (2021). Kawasaki disease in children younger than 6 months of age: characteristics of a Spanish cohort. European Journal of Pediatrics. 181(2). 589–598. 4 indexed citations

13.

Quartier, Pierre, Е.I. Alexeeva, Tamás Constantin, et al.. (2020). Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open‐Label, Randomized Study. Arthritis & Rheumatology. 73(2). 336–346. 23 indexed citations

14.

Fernández-Cooke, Elisa, Judith Sánchez-Manubens, Jordi Antón, et al.. (2019). Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011-2016): KAWA-RACE study group. PLoS ONE. 14(5). e0215665–e0215665. 41 indexed citations

15.

Lepri, Gemma, Donato Rigante, Silvia Bellando-Randone, et al.. (2019). Clinical-Serological Characterization and Treatment Outcome of a Large Cohort of Italian Children with Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection and Pediatric Acute Neuropsychiatric Syndrome. Journal of Child and Adolescent Psychopharmacology. 29(8). 608–614. 22 indexed citations

16.

Fernández-Cooke, Elisa, et al.. (2019). Previous or coincident infections with suspected Kawasaki disease. Should we change our approach?. SHILAP Revista de lepidopterología. 90(4). 213–218. 5 indexed citations

17.

Magro, Paola, Ilaria Izzo, Salvatore Casari, et al.. (2017). A strange case of Malaria in a Nigerian native boy.. Mediterranean Journal of Hematology and Infectious Diseases. 9(1). e2017023–e2017023. 1 indexed citations

18.

Gattorno, Marco, Laura Obici, Jordi Antón, et al.. (2012). Efficacy and Safety of Canakinumab in Patients with TNF Receptor Associated Periodic Syndrome. UCL Discovery (University College London). 8 indexed citations

19.

Calvo, Cristina, Pere Soler‐Palacín, Jesús Saavedra‐Lozano, et al.. (2010). Documento de Consenso de la Sociedad de Infectología Pediatrica y la Sociedad de Reumatología Pediatrica sobre el diagnóstico diferencial y el abordaje terapéutico de la fiebre recurrente. Anales de Pediatría. 74(3). 194.e1–194.e16. 7 indexed citations

20.

Ferrari, Simona, Vassilios Lougaris, Stefano Giuseppe Caraffi, et al.. (2007). Mutations of the Igβ gene cause agammaglobulinemia in man. The Journal of Experimental Medicine. 204(9). 2047–2051. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact